Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
- Published in:
- Current Oncology, 2023, v. 30, n. 11, p. 9940, doi. 10.3390/curroncol30110722
- By:
- Publication type:
- Article